利多卡因止痛软膏因缺乏儿童抗药盖，对儿童有误服风险，被全国召回。 A lidocaine pain ointment is recalled nationwide for lacking child-resistant lids, posing ingestion risks to children.

由于缺乏抗儿童包装,正在全国收回在沃尔玛、目标、亚马逊等地广泛出售的含利多卡因的止痛药膏。 A widely sold pain relief ointment containing lidocaine, available at Walmart, Target, and Amazon, is being recalled nationwide due to the lack of child-resistant packaging. 2024年4月至2025年10月期间出售了大约50 000个集装箱的UPC 860006498115被召回。 The recall affects about 50,000 containers with UPC 860006498115, sold between April 2024 and October 2025. 虽然产品成分和效果不受影响,但没有安全盖子会增加意外摄取的风险,特别是儿童摄入的风险。 While the product’s ingredients and effectiveness are not compromised, the absence of safety lids raises risks of accidental ingestion, especially by children. 敦促消费者将产品远离儿童,并与制造商Plantimex联系,以便免费盖上儿童安全盖,恢复安全使用。 Consumers are urged to keep the product away from children and contact manufacturer Plantimex for a free child-safety lid to restore safe use.